Updated Financial Standings, Company Announcements, and Upcoming Investors Conferences - Research Report on Zimmer, Boston Scientific, Hospira, Elan, and Incyte

NEW YORK, December 10, 2013 /PRNewswire/ --

Editor Note: For more information about this release, please scroll to bottom.

Today, Analysts' Corner announced new research reports highlighting Zimmer Holdings, Inc. (NYSE: ZMH), Boston Scientific Corporation (NYSE: BMX), Hospira Inc. (NYSE: HSP), Elan Corporation, plc (NYSE: ELN), and Incyte Corporation (NASDAQ: INCY). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.

Zimmer Holdings, Inc. Research Report

On December 5, 2013, Zimmer Holdings, Inc.'s (Zimmer) stock increased 0.42%, ending the day at $90.45. Over the previous three trading sessions, shares of Zimmer declined 0.65% compared to the Dow Jones Industrial Average which declined 1.17% during the same period. The Full Research Report on Zimmer Holdings, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.AnalystsCorner.com/r/full_research_report/9db9_ZMH

--

Boston Scientific Corporation Research Report

On December 5, 2013, Boston Scientific Corporation's (Boston Scientific) stock increased 0.27%, ending the day at $11.34. Over the previous three trading sessions, shares of Boston Scientific declined 2.49% compared to the Dow Jones Industrial Average which also declined 1.17% during the same period. The Full Research Report on Boston Scientific Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.AnalystsCorner.com/r/full_research_report/5640_BSX

--

Hospira Inc. Research Report

On December 5, 2013, Hospira Inc.'s (Hospira) stock increased 1.96%, ending the day at $41.00. Over the previous three trading sessions, shares of Hospira increased 2.27% compared to the Dow Jones Industrial Average which declined 1.17% during the same period. The Full Research Report on Hospira Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.AnalystsCorner.com/r/full_research_report/1f43_HSP

--

Elan Corporation, plc Research Report

On December 5, 2013, Elan Corporation, plc's (Elan) stock increased 0.28%, ending the day at $18.05. Over the previous three trading sessions, shares of Elan declined 0.50% compared to the Dow Jones Industrial Average which also declined 1.17% during the same period. The Full Research Report on Elan Corporation, plc - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.AnalystsCorner.com/r/full_research_report/e996_ELN

--

Incyte Corporation Research Report

On November 25, 2013, Incyte Corporation (Incyte) reported that the Company will participate at the Oppenheimer 24th Annual Healthcare Conference which will be held on December 11, 2013. The Company's events page showed that the said conference will be held at the Crowne Plaza Hotel in New York, New York City, and will start at 10:40 a.m. ET. Incyte informed that the presentation will be webcast live, and will be available for replay. The Full Research Report on Incyte Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.AnalystsCorner.com/r/full_research_report/076e_INCY

----

EDITOR NOTES:

  1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
  2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
  3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
  4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com.
  5. For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com.
  6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Ananya Ghosh, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts' Corner

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.